Bacil Pharma P/B Ratio
Bacil Pharma (BACPHAR) P/B ratio is 3.06 (High), book value per share ₹17.86 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. View Bacil Pharma yearly highs lows for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
BACPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Bacil Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 3.06 (High). For live price, earnings yield and the full fundamental profile, see BACPHAR stock price BSE.
- Stock appears overvalued with PB of 3.06, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 72.7% below historical average
- Trading at premium to sector average PB of -0.94
Bacil Pharma P/B Ratio Historical Trend
BACPHAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with BACPHAR stock valuation models to assess whether the stock is under or overvalued.
BACPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Bacil Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 2.0 | ₹17.86 | ₹35.64 | ₹25 | Moderate |
| 2024 | 38.04 | ₹1.43 | ₹54.34 | ₹1 | High |
| 2023 | 4.47 | ₹1.43 | ₹6.38 | ₹1 | High |
| 2022 | 6.58 | ₹1.43 | ₹9.40 | ₹1 | High |
| 2021 | 5.0 | ₹1.43 | ₹7.15 | ₹1 | High |
BACPHAR vs Healthcare Peers — P/B Ratio Comparison
Bacil Pharma P/B 3.06 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |